Hydroxyzine Shortage: What Providers and Prescribers Need to Know in 2026

Hydroxyzine occupies a unique position in the prescribing landscape: it is a first-generation antihistamine with well-established anxiolytic, antipruritic, and sedative properties, it is not a controlled substance, and it is inexpensive. These characteristics have made it increasingly prescribed — including through telehealth — as an alternative to benzodiazepines.

Yet patients are increasingly reporting difficulty filling hydroxyzine prescriptions at their local pharmacies. This briefing provides prescribers with an accurate picture of the current supply situation, clinical considerations for formulation flexibility, and practical tools to help patients navigate access challenges.

Current Supply Status: No FDA-Declared Shortage, But Access Problems Are Real

As of 2026, oral hydroxyzine is not on the FDA's active drug shortage list for oral formulations. Multiple generic manufacturers supply hydroxyzine HCl tablets (Amneal, Hikma, Mylan/Viatris, others) and hydroxyzine pamoate capsules (Amneal, Avet, Sandoz, Chartwell, Teva, among others).

However, a formal absence from the shortage database does not guarantee availability at any given pharmacy. The structure of the generic drug market — fragmented wholesaler contracts, lean pharmacy inventory practices, and uneven regional distribution — creates real-world access gaps that patients experience as a shortage.

What Is Driving Increased Demand?

Several converging factors are increasing hydroxyzine prescription volume:

• Benzodiazepine deprescribing initiatives. Regulatory scrutiny of benzodiazepine prescribing, updated guidelines, and patient preference for non-controlled medications have increased hydroxyzine prescribing for anxiety.
• Telehealth prescribing growth. Hydroxyzine can be prescribed via telehealth without in-person visit requirements. Major telehealth platforms have made hydroxyzine a first-line anxiety option, driving significant prescription volume increases.
• Increased off-label use. Growing use as a sleep aid and for alcohol withdrawal management has expanded the patient population being treated.

Clinical Considerations for Formulation Flexibility

When a patient cannot obtain their prescribed formulation, consider the following:

HCl vs. Pamoate Salt: Hydroxyzine hydrochloride and hydroxyzine pamoate contain the same active drug with equivalent clinical effects. The pamoate form has slightly lower bioavailability per milligram due to molecular weight differences, but the formulations are generally considered therapeutically equivalent for most uses. A prescription specifying "hydroxyzine HCl OR pamoate" provides maximum dispensing flexibility.

Dose equivalence consideration: Because the two salt forms have different molecular weights, the equivalent milligram doses are not perfectly interchangeable on a 1:1 basis in terms of active hydroxyzine content. For anxiolytic dosing in adults, clinical differences at standard doses (25-50 mg) are typically minimal, but this warrants documentation.

Clinical Alternatives When Hydroxyzine Is Unavailable

If hydroxyzine cannot be found after reasonable effort, consider the following clinical alternatives based on indication:

For anxiety (GAD, situational):

• Buspirone: non-controlled, effective for GAD; onset 2-4 weeks; 15-60 mg/day divided BID-TID
• SSRIs (sertraline, escitalopram): first-line for chronic GAD; 4-6 week onset; monitor for activation symptoms early in treatment
• Pregabalin: effective for GAD; off-label but evidence-supported; Schedule V controlled

For allergic pruritus / urticaria:

• Cetirizine (hydroxyzine's primary active metabolite): OTC, 10 mg daily; effective for most pruritic conditions
• Fexofenadine or loratadine: OTC, non-sedating; appropriate for daytime use

For pre-procedure sedation:

• Midazolam or lorazepam (benzodiazepines): appropriate clinical substitutes in perioperative settings where controlled substances can be managed

38,781+ patients found their medications in stock

38K+

Find Hydroxyzine In Stock Today →

Special Population Considerations

Keep in mind these population-specific considerations when managing hydroxyzine access issues:

• Elderly patients: Hydroxyzine is on the Beers Criteria list of medications to avoid in older adults due to increased risk of oversedation and confusion. If shifting an older patient away from hydroxyzine, this is an opportunity to reassess rather than substitute.
• Pregnancy: Hydroxyzine is contraindicated in the first trimester and generally avoided throughout pregnancy. If a pregnant patient was taking it, coordinate with OB or MFM for appropriate alternatives.
• Pediatric patients: For children requiring the oral syrup formulation (10 mg/5 mL) for pruritus, availability issues may be more acute. Consider age-appropriate OTC antihistamines as a bridge.

How to Help Your Patients Find Hydroxyzine

Referring patients to medfinder is one of the most practical tools you can offer. medfinder calls pharmacies near the patient to check real-time stock availability and texts the patient which pharmacies have their medication. This eliminates the frustration of patients calling pharmacy after pharmacy and can significantly reduce your office call volume around medication access questions.

For a practical step-by-step guide on supporting patients with hydroxyzine access, see our provider guide to helping patients find hydroxyzine.